Delivery technologies

Viiv weighs in on FDA approval of long-acting HIV treatment

22-Feb-2022 By Jenni Spinner

A representative from the HIV-centered pharmaceutical company shares thoughts and perspective on the every-two-month treatment and how it might help patients.

Collaboration to advance development of cancer therapies

14-Feb-2022 By Jenni Spinner

Cullinan Oncology has formed a strategic partnership with the Icahn School of Medicine at Mount Sinai to research and develop targeted therapies for cancer.

TFF completes enrollment in early-phase trial of inhaled COVID-19 therapy

10-Feb-2022 By Nick Taylor

The pharmaceutical company, which uses thin-film freezing to develop inhalable therapies, has completed enrollment in the first phase for its drug candidate.

ViiV Healthcare long-acting HIV treatment secures FDA approval

07-Feb-2022 By Jenni Spinner

The HIV-focused pharma company announced the agency has approved Cabenuva for administration as few as six times a year for adults living with the virus.

People on the Move: February 2022

03-Feb-2022 By Jenni Spinner

This month’s announcements include new hires, promotions, acquisitions, and other events from Saama, Javara, Firma, GlaxoSmithKline, and other companies.

FDA approves IND for clinical trial evaluating CBD-based drug

25-Jan-2022 By Jenni Spinner

The agency has given the go-ahead on an IND application for a study evaluating Ananda Scientific’s Nantheia ATL5, a candidate for treating opioid use disorder.

San Diego cell therapy CDMO acquired by Great Point Partners

13-Jan-2022 By Rachel Arthur

Performance Cell Manufacturing, a CDMO with a focus on manufacturing cell therapies, has been acquired by Great Point Partners and will now operate under the name Cellipont Bioservices.

Novartis reports good news from COVID-19 antiviral trial

12-Jan-2022 By Jenni Spinner

The pharma firm and collaborator Molecular Partners reported positive data out of their Phase II study for ensovibep, an antiviral for treating the virus.

Tech Innovations: December 2021

21-Dec-2021 By Jenni Spinner

This month’s collaborations, tech partnerships, new facilities, and other happenings includes news from Flywheel, Medable, Veeva, and other organizations.

Novo Nordisk weight-management treatment hits supply snag

20-Dec-2021 By Jenni Spinner

The pharmaceutical company has announced GMP-related challenges with a manufacturer contracted to fill syringes for Wegovy pens headed to the US market.

ASH 2021 sees Novartis launch a 'next-generation' CAR-T platform

14-Dec-2021 By Jane Byrne

Novartis has introduced its T-Charge platform at ASH 2021, which it says will serve as the foundation for various new investigational CAR-T cell therapies in its pipeline.

New inhaled SARS-CoV-2 antibody treatment set to enter clinical trials

13-Dec-2021 By Rachel Arthur

Memo Therapeutics AG will receive CHF 10.5m (US $11.4m) from the Swiss government to clinically develop a SARS-CoV-2 antibody against COVID-19, allowing it to start Phase 1 studies in Q1, 2022.

Roquette plans to open doors of new US innovation center

08-Dec-2021 By Jenni Spinner

Sited in Pennsylvania, the excipients specialist’s new facility reportedly will work toward advancing drug delivery research and boosting speed to market.

FDA approves BioMarin drug to treat dwarfism in children

22-Nov-2021 By Jenni Spinner

The US agency has granted approval to Voxzogo, an injectable drug designed to aid growth in children with achondroplasia, the most common form of dwarfism.

Tech Innovations: November 2021

18-Nov-2021 By Jenni Spinner

This month’s launches, expanded facilities, partnerships, and other news includes items from Veeva, Hovione, Florence, Medidata, and other notable firms.

TFF completes dosing in Phase Ib clinical study for asthma drug

15-Nov-2021 By Jenni Spinner

The firm is investigating viability of voriconazole inhalation powder, intended to treat and prevent invasive pulmonary aspergillosis in asthma patients.

Baxter investing $100m to bolster German sterile fill/finish facility

11-Nov-2021 By Jenni Spinner

The infusion of funds in the Halle/Westfalen, Germany manufacturing complex is intended to help meet growing global demand for injectable pharmaceuticals.

cphi worldwide

Variable-dose pen injector platform designed for simple use

11-Nov-2021 By Jenni Spinner

Stevanato Group is showcasing its SG Alina disposable, variable-dose pen injector platform, available with customizable features, at CPhI Worldwide 2021.

Neopac recyclable barrier tubes land sustainability award

10-Nov-2021 By Jenni Spinner

Polyfoil MMB mono-material tubes, designed to be recyclable, landed top honors in the Excellence in Sustainability at the recent Pharmapack Awards program.

CPHI WORLDWIDE

Carrier solution addresses challenging liquid APIs: W.R. Grace

03-Nov-2021 By Jenni Spinner

The CPhI Worldwide exhibitor will show Syloid XDP, a silica carrier designed to convert liquid, waxy, or oily active ingredients into free-flowing powders.

CPhI Worldwide

Gerresheimer develops delivery device for drugs with higher viscosity

03-Nov-2021 By Jane Byrne

CPhI Worldwide will see Gerresheimer showcase its latest developments in primary packaging, drug delivery systems for newly developed biologics along with medical and diagnostic products.

CPHI WORLDWIDE

Hybrid CPhI Worldwide 2021 a ‘celebration’ of pharma industry

02-Nov-2021 By Jenni Spinner

The global pharmaceutical industry event is returning to the real world November 9-11 this year, with online content for professionals opting not to travel.

Potential COVID-19 treatment to wrap up Phase III trial

26-Oct-2021 By Jenni Spinner

Appili Therapeutics reports it has enrolled the last patient for its Phase III study of Avigan/Reeqonus (favipiravir), developed in alliance with AiPharma.

‘Digital transformation’ requires enterprise-wide change: Rockwell Automation

19-Oct-2021 By Jenni Spinner

To fully reap the benefits of tech advances, a company leader advises, a life-sciences firm must embrace change and connection throughout the operation.

Digital revolution transforming drug development: West Pharma

18-Oct-2021 By Jenni Spinner

A leader from the drug development and manufacturing firm talks about the ways in which advanced digital tools stand to revolutionize the pharma field.

AAPS PharmSci 360

PharmSci 360 invites industry pros to ‘rethink and evolve’

14-Oct-2021 By Jenni Spinner

The conference (with online and in-person content) is slated to gather professionals for deep conversations and lively collaboration on important topics.

CytoReason, Summit tap into AI on Japanese drug development effort

12-Oct-2021 By Jenni Spinner

The AI technology firm and pharma services company are joining to help one of the country’s leading pharmaceutical firms develop a promising drug candidate.

Data advances, environmental factors driving device innovation: Pharmapack

11-Oct-2021 By Jenni Spinner

Organizers of the drug delivery and packaging event have shared an industry report that reveals what is likely to push innovation forward in the future.

Merck: COVID-19 oral antiviral drug reduces risk of death

01-Oct-2021 By Jenni Spinner

The pharma firm reports molnupiravir was shown to cut risk of hospitalization or death by 50% compared to placebos in a positive interim Phase III analysis.

Update on FDA COVID approvals, actions, and advice

24-Sep-2021 By Jenni Spinner

As COVID-19 and its variants continue their attack, the agency maintains its position of overseer and giver of advice on various treatments and vaccines.

US pharma market ahead of Europe on drug device innovation: Pharmapack

21-Sep-2021 By Jenni Spinner

A report from the industry event’s organizers indicates American companies have an edge on drug delivery innovation but lag in operational sustainability.

FDA approves IND application for peanut allergy drug candidate

16-Sep-2021 By Jenni Spinner

The US agency has given the go-ahead to Cour Pharmaceuticals to evaluate the safety and efficacy of CNP-201, a drug intended to treat peanut allergies.

Gates Foundation, Exscientia enter $70m agreement to develop COVID-19 treatments

14-Sep-2021 By Jenni Spinner

The pharma tech firm has forged a four-year partnership with the foundation to develop antivirals for COVID-19 and other viruses with pandemic potential.

GSK rhinosinusitis drug receives thumbs up from the FDA

09-Sep-2021 By Jenni Spinner

Nucala, a monoclonal antibody indicated for patients with chronic rhinosinusitis with nasal polyps, has been approved by the Food and Drug Administration.

People on the Move: September 2021

02-Sep-2021 By Jenni Spinner

This month’s news on new hires, board launches, acquisitions, and other important news includes items on Pfizer, Javara, Clinical Ink, and other companies.

Inflammasome develops combo HIV/birth control implant

23-Aug-2021 By Jenni Spinner

Thanks in part to grants from the Gates Foundation, the company has come up with a bioerodible implant that combines HIV prevention and birth control.

3D tablet printing needs the right excipient: DFE Pharma

18-Aug-2021 By Jenni Spinner

The excipients specialist shares findings from its research into the ins and outs of 3D powder bed printed tablets and how it can benefit drug development.

Philip Morris acquires another inhaled-drug pharma firm

10-Aug-2021 By Jenni Spinner

The US-based company continues its move away from smoking products with the purchase of drug developer OtiTopic, as part of its Beyond Nicotine initiative.

UIC studying IV drug as potential COVID-19 treatment

10-Aug-2021 By Emily Jarecki

The University of Illinois at Chicago has been given $6m from the US Department of Defense to develop a potential treatment for severe cases of COVID-19.

Virtual reality technology transforming COVID-19 drug discovery

09-Aug-2021 By Jenni Spinner

Nanome’s virtual reality tech is being put to use by Oak Ridge National Laboratory and top pharma firms to study COVID-19 and explore drug candidates.

mRNA and beyond: Opportunities for US biologics

03-Aug-2021 By Staff reporter

The success of mRNA vaccine technology could be one of the new opportunities for US pharmaceutical manufacturing looking forward, with pandemic investments helping turbocharge the sector.

Spotlight on single-use systems: 3 trends driving demand

03-Aug-2021 By Staff reporter

Adoption of single-use technologies has grown exponentially over the last decade: but what will drive the tech forward in the coming years?

Wave of acquisitions hits pharma industry this week

15-Jul-2021 By Jenni Spinner

The past several days have seen a relatively large number of industry acqusitions, with Lilly, Phillip Morris, WCG, CTI and others making notable buys.

People on the Move: July 2021

08-Jul-2021 By Jenni Spinner

This month’s news on hires, promotions, acquisitions, and expansions includes items about Javara, Elligo, Lonza, Yourway, Medable, and other notable firms.

DIA Annual Meeting 2021

DIA 2021 will explore the potential of RNA based therapeutics

17-Jun-2021 By Jane Byrne

In recent years, it has become clear that RNA molecules are an emerging as a class of therapeutics of relevance to multiple diseases, most recently including COVID-19 vaccines.

People on the Move: June 2021

02-Jun-2021 By Jenni Spinner

This month’s roundup of hires, acquisitions, anniversaries, and other announcements includes news from Premier Research, Cytel, ACG, and other companies.

Special Edition: BIO DIGITAL 2021

Italy sees hike in biotech R&D investments, at rate higher than EU average

02-Jun-2021 By Jane Byrne

A robust research and innovation ecosystem makes Italy an attractive life sciences hotspot, according to a post from an Italian trade delegation at Bio Digital 2021.

Special Edition: BIO DIGITAL 2021

‘HIV remains a pandemic of inequalities’: The fight against HIV/AIDS, 40 years on

02-Jun-2021 By Rachel Arthur

June 2021 marks the 40th anniversary of the publication of the first reported cases of AIDS in the US. A session at BIO Digital – featuring Dr. Anthony Fauci, Director of NIAID at the NIH – will focus on four decades of innovation as well as the critical...

Newly launched ‘skunkworks’ firm seeks to elevate drug development

27-May-2021 By Jenni Spinner

Created by an industry veteran with more than 20 years’ experience, Protodigm aims to offer innovation and expertise to pharmaceutical industry clients.